Device Specialty Access

Gelpoint Path Transanal Access Platform

Payments companies reported to CMS as associated with Gelpoint Path Transanal Access Platform. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$4,504associated payments (2023-2025)
4clinicians with associated payments
1company reporting

By year

2023 $3,601
2024 $243
2025 $660

Payments reported as associated with Gelpoint Path Transanal Access Platform, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Colon & Rectal Surgery $4,439
Surgery $64.83

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Gelpoint Path Transanal Access Platform

These are the largest totals companies reported as associated with Gelpoint Path Transanal Access Platform. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Richard Whelan New York, NY Colon & Rectal Surgery $3,009.91
Matthew Albert Altamonte Springs, FL Colon & Rectal Surgery $929.19
Monika Krezalek Highland Park, IL Colon & Rectal Surgery $500.00
Andrew-Paul Deeb Sioux Falls, SD Surgery $64.83

Prescribed Gelpoint Path Transanal Access Platform?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.